Board of Directors


Paolo Paoletti, M.D.

Italian (USA Citizenship), 69 
Board Member (Independent, elected by the General Meeting); Chairman of the Scientific Committee; Member of the Compensation Committee 
First elected 2015, current term expires 2021
Special Competences
Extensive experience in research, development and commercialization in the pharmaceutical industry. Successfully conducted submissions and approvals of new cancer drugs and new indications in the USA and in Europe. Responsible for seven new medicines for cancer patients during his 10 years at GlaxoSmithKline and one new cancer medicine during his time at Eli Lilly.
Current Position, including Managerial Positions
Acting CEO for GammaDelta Therapeutics Limited
Current Board Positions
Member: PsiOxus Therapeutics Limited, FORMA Therapeutics

Back To Board of Directors